Literature DB >> 16574111

Cytochrome b(5) is a major reductant in vivo of human indoleamine 2,3-dioxygenase expressed in yeast.

Eduardo Vottero1, David A Mitchell, Michael J Page, Ross T A MacGillivray, Ivan J Sadowski, Michel Roberge, A Grant Mauk.   

Abstract

The evolutionary relationship of indoleamine 2,3-dioxygenase (IDO) to some gastropod myoglobins suggests that IDO may undergo autoxidation in vivo such that one or more currently unidentified electron donors are required to maintain IDO heme iron in the active, ferrous state. To evaluate this hypothesis we have used yeast knockout mutants in combination with a recently developed yeast growth assay for IDO activity in vivo to demonstrate a role for cytochrome b(5) and cytochrome b(5) reductase in maintaining IDO activity in vivo.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16574111     DOI: 10.1016/j.febslet.2006.03.034

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  NADH oxidase activity of indoleamine 2,3-dioxygenase.

Authors:  Federico I Rosell; Hsin H Kuo; A Grant Mauk
Journal:  J Biol Chem       Date:  2011-06-20       Impact factor: 5.157

Review 2.  Amino acid catabolism: a pivotal regulator of innate and adaptive immunity.

Authors:  Tracy L McGaha; Lei Huang; Henrique Lemos; Richard Metz; Mario Mautino; George C Prendergast; Andrew L Mellor
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

3.  Catalytic activity of human indoleamine 2,3-dioxygenase (hIDO1) at low oxygen.

Authors:  Ayodele O Kolawole; Brian P Hixon; Laura S Dameron; Ian M Chrisman; Valeriy V Smirnov
Journal:  Arch Biochem Biophys       Date:  2015-02-21       Impact factor: 4.013

4.  Evolution of vertebrate indoleamine 2,3-dioxygenases.

Authors:  Hajime Julie Yuasa; Miwa Takubo; Ayumi Takahashi; Tetsuo Hasegawa; Hiroshi Noma; Tomohiko Suzuki
Journal:  J Mol Evol       Date:  2007-11-17       Impact factor: 2.395

Review 5.  Structure and reaction mechanism in the heme dioxygenases.

Authors:  Igor Efimov; Jaswir Basran; Sarah J Thackray; Sandeep Handa; Christopher G Mowat; Emma Lloyd Raven
Journal:  Biochemistry       Date:  2011-03-18       Impact factor: 3.162

Review 6.  Inflammation and repeated infections in CGD: two sides of a coin.

Authors:  Taco Kuijpers; Rene Lutter
Journal:  Cell Mol Life Sci       Date:  2011-11-15       Impact factor: 9.261

Review 7.  Tryptophan-catabolizing enzymes - party of three.

Authors:  Helen J Ball; Felicita F Jusof; Supun M Bakmiwewa; Nicholas H Hunt; Hajime J Yuasa
Journal:  Front Immunol       Date:  2014-10-09       Impact factor: 7.561

Review 8.  A short history of heme dioxygenases: rise, fall and rise again.

Authors:  Emma L Raven
Journal:  J Biol Inorg Chem       Date:  2016-12-01       Impact factor: 3.358

9.  Immune-modulating enzyme indoleamine 2,3-dioxygenase is effectively inhibited by targeting its apo-form.

Authors:  Micah T Nelp; Patrick A Kates; John T Hunt; John A Newitt; Aaron Balog; Derrick Maley; Xiao Zhu; Lynn Abell; Alban Allentoff; Robert Borzilleri; Hal A Lewis; Zeyu Lin; Steven P Seitz; Chunhong Yan; John T Groves
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-12       Impact factor: 11.205

Review 10.  Reactive Oxygen Species in Autoimmune Cells: Function, Differentiation, and Metabolism.

Authors:  Weiji Lin; Pan Shen; Yaqin Song; Ying Huang; Shenghao Tu
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.